WASHINGTON (AP) — A federal policy that allows the Food and Drug Administration to withhold key details about drugs, medical implants and other products is coming under new pressure from open government advocates.

A coalition of public interest groups asked the FDA on Friday to overturn the decades-old policy used to black out sections of federal documents before turning them over to journalists, investigators and others who request information from the government.